Sionna Corp (SION): O‘sishni hisobga olgan narx-foyda koeffitsiyenti

Sionna Corp (SION) tovar belgisi

O'sish sur'atining past baholanishi tahlili aktivning qiymat dinamikasini ko'rsatadi, bunda ko'rsatkich hozirda 0.00 darajasida. Sionna Therapeutics Inc (SION) kichik molekulalarni yaratish orqali kistik fibroz terapiyasi bozoridagi monopoliyani buzishni maqsad qilgan. Ishlab chiqish jarayoni hujayra funksiyalarini regeneratsiya qilish bo'yicha ilmiy markazlar bilan sinergiyada olib borilmoqda. Ushbu innovatsion asosning muvaffaqiyati ventura investitsiyalariga va FDA qarorlariga bog'liq.

Narx-foyda va o‘sish multiplikatori: Sionna Therapeutics, Inc. (SION) 08.02.2025 - 15.11.2026 uchun

Sionna Therapeutics (SION) kompaniyasining tahliliy kesimlari

- aksiya narxi va konsensus maqsadli narx:
- birja kapitallashuvi ma'lumotlari:
Kompaniyaning umumiy tahlili:SION - Sionna Corp
sionnatx.com brendining mahsuloti

Sionna Therapeutics Inc (SION) kompaniyasining biotexnologiya sektori uchun, u yerda kistik fibroz terapiya platformasining samaradorligi kapital xarajatlarini optimallashtiradi, hisoblangan PEG koeffitsiyenti investitsiyalarning jozibadorligi ko'rsatkichi bo'lib xizmat qiladi. Ushbu koeffitsiyent joriy P/E multiplikatorini kutilayotgan sof foyda dinamikasi bilan bog'laydi, bu esa investorlarga aktivlarning kengayish sur'atlariga nisbatan qanchalik past baholanganlik darajasini aniqlash va qiymat o'sishining uzoq muddatli salohiyatini baholash imkonini beradi.

Sionna Therapeutics Inc raqobatchilari

PEG multiplikatori Tempus (TEM)|PEG multiplikatori QGEN (Qiagen NV)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Ionis (IONS)|repligen.com - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Avidity|CRSP (CRISPR Therapeutics Corp) - Narx-foyda va o‘sish multiplikatori|GeneDx Corp - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Ultragenyx|O‘sish sur’atiga tuzatilgan narx-foyda beamtx.com BEAM|Narx-foyda va o‘sish multiplikatori SRPT (Sarepta Therapeutics, Inc.)|TWST - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati 10x TXG|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati NTLA (Intellia)|Stoke Corp - PEG multiplikatori|BLFS: Narxning foydaga va o‘sish sur’atiga nisbati|WVE: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Maze Tx (MAZE)|Narxning foydaga va o‘sish sur’atiga nisbati Prime Medicine, Inc.|TSHA (Taysha) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori QURE (uniQure Pharma)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati meiragtx.com|Narxning foydaga va o‘sish sur’atiga nisbati REGENXBIO RGNX|SLDB - Narx-foyda va o‘sish multiplikatori|Ocugen, Inc. - PEG multiplikatori|PACB (Pacific Biosciences of California) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|BNTC: PEG multiplikatori|DSGN - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|RCKT (Rocket Pharma) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati FDMT|Narxning foydaga va o‘sish sur’atiga nisbati Lexeo Therapeutics, Inc. (LXEO)|Korro Bio Inc. - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|editasmedicine.com - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati silence-therapeutics.com (SLN)|PRQR: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda codexis.com|SGMO: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Nautilus Biotechnology Inc (NAUT)|Narx-foyda va o‘sish multiplikatori MGX|DTIL (Precision BioSciences) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Generation Bio Corp (GBIO)|Boundless Bio - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Exicure, Inc. XCUR|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti IMNN|PHIO - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Mustang Bio Inc MBIO|RNAZ: PEG multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti BNGO|APDN (Applied DNA Sciences Inc) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Bluebird Bio BLUE|PEG multiplikatori IPA|Omega Therapeutics (OMGA) - Narxning sof foyda o‘sishiga nisbati|PEG multiplikatori OMIC (Singular Genomics Systems Inc)|Narxning sof foyda o‘sishiga nisbati Regulus Therapeutics Inc|SYRS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti TBIO (Codex DNA)|TCON: PEG multiplikatori|UBX - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati